Main > > >EDEMA. *

---

Cardio.>DiUretics. SpironoLactone Oral Suspension. 25 mg/5 mL.
Antagonist of Aldosterone.
- Indications:
treatment of NYHA Class III-IV heart
failure and reduced ejection fraction
to increase survival, manage edema,
and to reduce the need for
hospitalization for heart failure; use
as an add-on therapy for the treatment
of hypertension, to lower blood
pressure; the management of edema in
adult cirrhotic patients when edema is
not responsive to fluid and sodium
restrictions.
USA Approval Date: 2017. 08.07.
USA Launch Date : 2017. 10.30.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 04.01








>EDEMA. *'s products
This section has no products